QA: Royalty Pharma plc in us_pharma/2025

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001802768_2026_Royalty_Pharma_plc.pdf

Logs

Graph

Absolute values for 0001802768, Royalty Pharma plc

  xvar xval
0 AssetsCurrent 1,528,091,000
1 IntangibleAssetsNetIncludingGoodwill 924,634,000
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 17,168,055,000
4 LiabilitiesCurrent 636,211,000
5 LiabilitiesNoncurrent 8,691,760,000
6 remainder_Liabilities 577,870,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 543,794,897
9 ResearchAndDevelopmentExpense 359,581,677
10 remainder_Expenses 123,574,821
11 remainder_Revenues 2,386,811,513
12 remainder_NetIncome -198,264,792
13 remainder_ComprehensiveNetIncome -77,663,032
  yvar yval
0 Assets 19,620,780,000
1 Liabilities 9,905,841,000
2 Expenses 1,026,951,395
3 Revenues 2,386,811,513
4 StockholdersEquity 9,714,939,000
5 NetIncome 1,161,595,326
6 ComprehensiveNetIncome 1,122,763,810
7 BaseVar 16,608,155,866
8 EconomicCapitalRatiobeforeLimitedLiability 1.51
9 EconomicCapitalRatio 2.69

Edgar->Model Mapping

Feature Distribution

Change over Time